Hengrui Medicine Posts Net Profit Growth  

出　　处：《China Chemical Reporter》2010年第4期15-15,共11页中国化工报导（英文版）

摘　　要：Jiangsu Hengrui Medicine Co.,Ltd.(SH:600276) reported on February 8th that itrecorded sales revenue of RMB3.029 billion and net profit of RMB665.7 million in2009,increasing 26.6% and 57.4% over one year earlier,respectively.Jiangsu Hengrui Medicine Co.,Ltd.,is China’s largest manufacturer ofantineoplastics formulation,with a domestic market share of 12%.It is

关 键 词：Jiangsu EARLIER REVENUE FORMULATION PROFIT manufac 

分 类 号：F426.72[经济管理—产业经济]